Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

Oxaliplatin 2Capecitabine 2toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Locally Advanced Colon Cancer × Clear all
NCT05732493 2023-02-17

TORCH-C

Fudan University

Phase 2 Unknown
120 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

NCT04389151 2020-05-15

Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

The First Affiliated Hospital of Xiamen University

Phase 2 Unknown
30 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

NCT04188158 2019-12-05

ELECLA

Universidad de León

Phase 2 Unknown
238 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡